SciELO - Scientific Electronic Library Online

 
vol.35 issue2Sport: physiological modifications and evaluation for the prevention of sudden death. (Part I)Acute mitral regurgitation secondary to rupture of the papillary muscle, after acute myocardial infarction during the COVID-19 pandemic. Case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Related links

Share


Revista Uruguaya de Cardiología

Print version ISSN 0797-0048On-line version ISSN 1688-0420

Abstract

FERNANDEZ, Amparo; ASADURIAN, Pablo; KUSTER, Fernando  and  DAYAN, Víctor. Biological prosthetic valve thrombosis. Rev.Urug.Cardiol. [online]. 2020, vol.35, n.2, pp.226-243.  Epub Aug 01, 2020. ISSN 0797-0048.  https://doi.org/10.29277/cardio.35.2.15.

Bioprosthetic valve thrombosis was considered a relatively rare entity. However, due to the increased use of bioprostheses in cardiac surgery and the advent of transcatheter biological prostheses, it has acquired more attention as a cause of prosthetic dysfunction. The long-term relevance of subclinical thrombosis has not yet been elucidated, nor are the optimal therapeutic strategies to prevent bioprosthetic valve thrombosis or thromboembolic complications. This review aims to provide a summary of the pathophysiology, diagnosis and treatment of bioprosthetic valve thrombosis to contribute to the knowledge of this pathology.

Keywords : Thrombosis; Bioprosthesis; Aortic Valve; Transcatheter Aortic Valve Replacement; Thromboembolism; Anticoagulants.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )